Read More Healthcare Industry News Keysight Technologies (NYSE: KEYS) launches wireless coexistence test platform for FDA-compliant devices Keysight launches an automated RF coexistence test platform to help engineers meet ANSI C63.27 and FDA guidance. Find out what it means for the sector. byVenkateshJanuary 27, 2026